Cognitive Assessment Program
Introducing a full-service, in-office EEG & ERP (Event Related Potential) system utilizing an FDA approved device that can diagnose and differentiate between several cognitive disorders.
Cognitive Assessment Program
Introducing a full-service, in-office EEG & ERP (Event Related Potential) system utilizing an FDA approved device that can diagnose and differentiate between several cognitive disorders.
Patient Benefits
Provider Benefits
Patient Benefits
Early Diagnosis Matters:
Recent clinical evidence and pharmaceutical advances have shown early diagnosis and treatment of Alzheimer's and Dementia can slow progression of the diseases.
Alzheimer's Association Endorsed:
The EEG with ERP test is listed on the Alzheimer's Association website as a recommended test.
Covered by Medicare:
Medicare both requires and fully covers a cognitive test as part of a patient's Annual Wellness Visit.
Multiple Tests in One Visit:
This system pairs EEG data with ERP (processing of external stimuli) and Audiometry (testing for hearing loss). This combined data provides a more complete clinical picture for improved patient care.
Provider Benefits
Reimbursement:
The system has a proven record of Medicare and Medicaid reimbursement and can provide a significant source of additional revenue for clinics and providers.
Multiple CPT Codes:
This is the only in-office EEG that has CMS approval to bill all of the following CPT codes from a single test: 95957, 95816, 92652, 92552
No Upfront Cost:
There is no cost for the equipment or office onboarding. Xenter will either provide a technician or train and pay a current staff member to run the test.
Fulfills AWV Medicare Requirement:
This test fulfills the requirement for a cognitive assessment, as specified by Medicare, for a patient's AWV (Annual Wellness Visit).
Precise, Actionable Reports:
Data from the cognitive assessment is reviewed by a Neurologist who creates a simple report and sends it back to the doctor and patient through the XenME app.
Increasing the Focus
In addition to the EEG + ERP cognitive assessment, combined data from blood and genetic testing can enhance diagnostic accuracy. Xenter makes all of this data available in the XenME app, empowering the patient to advocate for their health and the provider to take a proactive approach to patient care.
pTau 217 Test
A pTau (phosphorylated tau) blood test measures levels of a specific tau protein in the blood to help assess Alzheimer's disease risk and aid in diagnosis. Elevated levels of this protein are linked to Alzheimer's pathology in the brain and can indicate a higher risk of developing the disease, sometimes years before symptoms appear. The test is less invasive and potentially less costly than older methods like spinal taps or PET scans.
Genetic Testing for Alzheimer's, Parkinson's, and Dementia (A-P-D)
Genetic testing can establish risk factors for conditions based on genetic test results and identify risks for additional health-related symptoms. A simple buccal swab or saliva sample can be sent by our Xenter technician to a lab partner and findings sent back to the attending clinician quickly. Additional clarity provided by a genetic test can result in more personalized treatment and better symptom management for patients.
Downloads
Access peer-reviewed research papers supporting our cognitive diagnostics methodology.
Alzheimer's and Dementia Research
Comprehensive research paper on Alzheimer's disease and dementia diagnostics and cognitive assessment approaches.
Concussion Diagnosis & Prognosis
Clinical research on diagnosis and prognosis methodologies for concussion assessment and recovery tracking.
ERP Biomarkers for Alzheimer's
Research on Event-Related Potential biomarkers and their application in early Alzheimer's detection.
Schizophrenia Research
Clinical paper exploring cognitive assessment techniques and biomarkers related to schizophrenia.
All research papers are provided in PDF format.